Maia Biotechnology, Inc. MAIA
Institutional shares held
1.47 Million
0
calls
0
puts
Total value of holdings
$3.2M
$0
calls
$0
puts
Market Cap
$24.2M
10,935,900
Shares Out.
Institutional ownership
13.41%
# of Institutions
18
We take great care to ensure that the data presented and summarized in this overview for MAIA Biotechnology, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MAIA
View all-
Vanguard Group Inc Valley Forge, PA566KShares$1.25 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN377KShares$832,5370.56% of portfolio
-
Geode Capital Management, LLC Boston, MA193KShares$425,5640.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$173,5310.0% of portfolio
-
Centric Wealth Management68.2KShares$150,7630.05% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX45.7KShares$100,9970.0% of portfolio
-
State Street Corp Boston, MA34.4KShares$76,0240.0% of portfolio
-
Northern Trust Corp Chicago, IL32.1KShares$70,8760.0% of portfolio
-
Naviter Wealth, LLC22.2KShares$48,9910.01% of portfolio
-
Ubs Group Ag16.7KShares$36,8730.0% of portfolio
Latest Institutional Activity in MAIA
Top Purchases
Top Sells
About MAIA
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Insider Transactions at MAIA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2024
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
53,418
+9.4%
|
$53,418
$1.87 P/Share
|
|
Dec 13
2024
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
25,000
+2.16%
|
$25,000
$1.87 P/Share
|
|
Nov 01
2024
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
22,133
+5.38%
|
$44,266
$2.51 P/Share
|
|
Nov 01
2024
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
88,534
+17.83%
|
$177,068
$2.51 P/Share
|
|
Nov 01
2024
|
Steven M Chaouki Director |
BUY
Open market or private purchase
|
Direct |
22,133
+16.62%
|
$44,266
$2.51 P/Share
|
|
Nov 01
2024
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+9.46%
|
$200,000
$2.51 P/Share
|
|
Apr 25
2024
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
147,492
+12.8%
|
$294,984
$2.03 P/Share
|
|
Apr 25
2024
|
Ngar Yee Louie Director |
BUY
Open market or private purchase
|
Direct |
19,665
+1.66%
|
$39,330
$2.03 P/Share
|
|
Mar 14
2024
|
Steven M Chaouki Director |
BUY
Open market or private purchase
|
Direct |
34,641
+28.04%
|
$34,641
$1.17 P/Share
|
|
Mar 14
2024
|
Ngar Yee Louie Director |
BUY
Open market or private purchase
|
Direct |
170,940
+12.97%
|
$170,940
$1.17 P/Share
|
|
Mar 14
2024
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
170,940
+16.62%
|
$170,940
$1.17 P/Share
|
|
Mar 14
2024
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
69,282
+15.87%
|
$69,282
$1.17 P/Share
|
|
Mar 14
2024
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
6,928
+2.12%
|
$6,928
$1.17 P/Share
|
|
May 18
2023
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
1,200
+0.38%
|
$2,400
$2.47 P/Share
|
|
May 15
2023
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
3,000
+1.0%
|
$6,000
$2.63 P/Share
|
|
Apr 28
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+0.49%
|
$8,000
$2.5 P/Share
|
|
Apr 27
2023
|
Ngar Yee Louie Director |
BUY
Open market or private purchase
|
Direct |
48,000
+4.68%
|
$96,000
$2.25 P/Share
|
|
Apr 27
2023
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
8,500
+2.66%
|
$17,000
$2.25 P/Share
|
|
Apr 27
2023
|
Joseph F Mcguire Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,400
+31.88%
|
$8,800
$2.25 P/Share
|
|
Apr 27
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
133,300
+16.26%
|
$266,600
$2.25 P/Share
|
Last 12 Months Summary
Buy / Acquisition
931K
Shares
From
5
Insiders
| Open market or private purchase | 931K shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders